Overview

Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet

Status:
Not yet recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the treatment of low back and leg pain from sciatica.
Phase:
Phase 3
Details
Lead Sponsor:
Sollis Therapeutics, Inc.
Treatments:
Clonidine